Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Gattis

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
International Journal of Cardiology|February 7, 2018
Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trialsNicolas Vodovar, Alexandre Mebazaa, James L Januzzi, et al.
JACC. Cardiovascular Interventions|February 24, 2015
Insights from the early experience of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryJohn S Rumsfeld, David R Holmes, Wendy Gattis Stough, et al.
American Heart Journal|July 10, 2003
Vasopressin: a new target for the treatment of heart failureCraig R Lee, Michael L Watkins, J Herbert Patterson, et al.
European Journal of Heart Failure|August 28, 2007
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trialVic Hasselblad, Wendy Gattis Stough, Monica R Shah, et al.
Journal of Cardiac Failure|February 22, 2014
End-of-life care in patients with heart failureDavid J Whellan, Sarah J Goodlin, Michael G Dickinson, et al.
Journal of the American College of Cardiology|December 2, 2017
Role of Payers in the Development of Cardiovascular Therapeutics: Misalignment Between Approval and ReimbursementFaiez Zannad, Maria de Los Angeles Alonso Garcia, Jeffrey S Borer, et al.
Circulation. Heart Failure|March 23, 2012
When to stop a clinical trial early for benefit: lessons learned and future approachesFaiez Zannad, Wendy Gattis Stough, John J V McMurray, et al.
Journal of the American College of Cardiology|August 20, 2011
Influence of global region on outcomes in heart failure β-blocker trialsChristopher M O'Connor, Mona Fiuzat, Karl Swedberg, et al.
European Heart Journal|February 5, 2008
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definitionFaiez Zannad, Wendy Gattis Stough, Bertram Pitt, et al.
Journal of Cardiac Failure|July 3, 2007
Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) studyGerasimos Filippatos, Joseph Rossi, Donald M Lloyd-Jones, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Cardiology|February 7, 2018
Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trialsNicolas Vodovar, Alexandre Mebazaa, James L Januzzi, et al.
JACC. Cardiovascular Interventions|February 24, 2015
Insights from the early experience of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryJohn S Rumsfeld, David R Holmes, Wendy Gattis Stough, et al.
American Heart Journal|July 10, 2003
Vasopressin: a new target for the treatment of heart failureCraig R Lee, Michael L Watkins, J Herbert Patterson, et al.
European Journal of Heart Failure|August 28, 2007
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trialVic Hasselblad, Wendy Gattis Stough, Monica R Shah, et al.
Journal of Cardiac Failure|February 22, 2014
End-of-life care in patients with heart failureDavid J Whellan, Sarah J Goodlin, Michael G Dickinson, et al.
Journal of the American College of Cardiology|December 2, 2017
Role of Payers in the Development of Cardiovascular Therapeutics: Misalignment Between Approval and ReimbursementFaiez Zannad, Maria de Los Angeles Alonso Garcia, Jeffrey S Borer, et al.
Circulation. Heart Failure|March 23, 2012
When to stop a clinical trial early for benefit: lessons learned and future approachesFaiez Zannad, Wendy Gattis Stough, John J V McMurray, et al.
Journal of the American College of Cardiology|August 20, 2011
Influence of global region on outcomes in heart failure β-blocker trialsChristopher M O'Connor, Mona Fiuzat, Karl Swedberg, et al.
European Heart Journal|February 5, 2008
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definitionFaiez Zannad, Wendy Gattis Stough, Bertram Pitt, et al.
Journal of Cardiac Failure|July 3, 2007
Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) studyGerasimos Filippatos, Joseph Rossi, Donald M Lloyd-Jones, et al.
Pageof 10